![]() |
Shellee Grim PharmD |
My clinical practice is with the transplant-infectious diseases service; we work closely with the solid organ and bone marrow transplantation services at UIC to assist in the management of infectious complications. My research focus stems from clinical practice as I am interested in opportunistic pathogens, in particular, invasive fungal infections.
Education:
1995-2001 Washington State University, Pullman , Washington , B.S.
1995-2001 Washington State University College of Pharmacy , Pullman , Washington , Pharm.D.
Post-Doctoral Training:
2001-2003 Resident in Pharmacy Practice and Infectious Diseases
University of Kentucky Chandler Medical Center , Lexington , Kentucky
Selected publications:
- Grim SA, Slover CM, Sankary H, Oberholzer J, Benedetti E, Clark NM. Risk factors for wound healing complications in sirolimus-treated renal transplant recipients. Transplant Proc (in press).
- Jain R, Clark NM , Diaz-Linares M, Grim SA. Limitations of current antiretroviral agents and opportunities for development. Curr Pharm Des 2006;12(9):1065-74.
- Grim SA, Rapp RP, Martin CA, Evans ME. Trimethoprim/sulfamethoxazole: Is this a viable agent for the treatment of infections caused by methicillin-resistant Staphylococcus aureus ? Pharmacotherapy 2005;25(2):253-64.
- Grim SA , Romanelli F. Viread ® (tenofovir disoproxil fumarate). Ann Pharmacother 2003;37:849-59.
- Grim SA , Ryan M, Miles MV, Tang PH, Strawsburg RH, deGrauw TJ, Fakhoury TA, Baumann RJ. Correlation of levetiracetam concentrations between serum and saliva. Ther Drug Monitor 2003;25:61-6.

